Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

28.70
-0.1150-0.40%
Volume:232.89K
Turnover:6.73M
Market Cap:1.37B
PE:9.38
High:29.24
Open:28.60
Low:28.22
Close:28.81
Loading ...

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory
·
19 Feb

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory
·
14 Feb

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory
·
13 Feb

Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66

MT Newswires Live
·
04 Feb

Amphastar Pharmaceuticals Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
04 Feb

Amphastar downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
04 Feb

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46

MT Newswires Live
·
03 Feb

Correction: Amphastar did not report Q4 earnings this morning

TIPRANKS
·
23 Jan

Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock

Simply Wall St.
·
21 Jan

This Forgotten Market Sector Is Set to Shine in 2025 -- Barrons.com

Dow Jones
·
17 Jan

New Strong Sell Stocks for January 2nd

Zacks
·
02 Jan

New Strong Sell Stocks for December 31st

Zacks
·
31 Dec 2024

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Simply Wall St.
·
05 Dec 2024

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Zacks
·
05 Dec 2024

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey
·
01 Dec 2024

Amphastar Pharmaceuticals Initiated at Overweight by Wells Fargo

Dow Jones
·
22 Nov 2024